BIA submission to the Lord Hill review of UK listing rules

The BIA has written to Lord Hill responding to his call for evidence on the UK's listing rules. 

In the letter, we have said that the life sciences sector attracts high levels of international investment but relatively little from UK institional investors, and as a result, NASDAQ is the listing destination of choice for life science companies. We argue that this is not due to the UK's listing rules but NASDAQ's deep capital pool and experienced investors. 

More within